| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 10%+ Owner | $6,320,962 | 22 May 2023 | ||
| Robert Hofmeister | Chief Scientific Officer | $152,862 | 09 Dec 2021 | ||
| Kevin Tang | 10%+ Owner | $0 | 01 Jun 2023 | ||
| Axel Hoos | Director | 01 Jun 2023 | |||
| MPM SunStates Fund, L.P. | 10%+ Owner | 01 Jun 2023 | |||
| Andrew R. Allen | Director | 01 Jun 2023 | |||
| Shawn Tomasello | Director | 01 Jun 2023 | |||
| Eric Sullivan | Chief Financial Officer | 01 Jun 2023 | |||
| Rosemary Harrison | Chief Business & Strategy | 01 Jun 2023 | |||
| UBS Oncology Impact Fund L.P. | 10%+ Owner | 01 Jun 2023 | |||
| Ansbert Gadicke | Director, 10%+ Owner | 01 Jun 2023 | |||
| MPM BioVentures 2014, L.P. | 10%+ Owner | 01 Jun 2023 | |||
| Angela Justice | Chief People Officer | 01 Jun 2023 | |||
| Neil W. Gibson | Director | 01 Jun 2023 | |||
| Garry E. Menzel | President and CEO, Director | 01 Jun 2023 | |||
| Stephen W. Webster | Director | 01 Jun 2023 | |||
| Priti Hegde | Director | 01 Jun 2023 | |||
| Peter Olagunju | Chief Operating Officer | 01 Jun 2023 | |||
| Alfonso Quintas Cardama | Chief Medical Officer | 01 Jun 2023 |
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||